Parathyroid hormone-immunoradiometric assays as noninvasive predictors of renal osteodystrophy: The need for bone histomorphometric validation [9]

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 4, 2001, Pages 1841-1842

  Goodman, William G ^a   John, Markus R ^b   Jüppner, Harald ^b   Salusky, Isidro B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE;

ACCURACY; HORMONE DETERMINATION; HUMAN; IMMUNORADIOMETRIC ASSAY; LETTER; OSTEOMETRY; PARATHYROID HORMONE BLOOD LEVEL; PREDICTION; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; VALIDATION PROCESS;

EID: 0035030048     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.4.7436-9     Document Type: Letter

References (15)

1. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia
2. Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD
3. Secondary hyperparathyroidism in human kidney transplant recipients
4. The spectrum of bone disease in end-stage renal failure - An evolving disorder
5. A plastic osteodystrophy in diabetic patients
6. A plastic osteodystrophy without aluminum: The role of "suppressed" parathyroid function
7. Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity
8. Risk factors for renal osteodystrophy: A multivariant analysis
9. Renal bone disease in pediatric patients and young adults treated by hemodialysis in a childrens hospital
10. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy
11. Intermittent calcitriol therapy in secondary hyperparathyroidism: A comparison between oral and intraperitoneal administration
12. A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: Implications for PTH measurements in renal failure
13. A novel mechanism for skeletal resistance in uremia
14. Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: Importance in the interpretation of PTH values
15. A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples